A recent study has demonstrated that in a NAFLD model, lactylation at the Lys673 site of FASN inhibits fatty acid synthase activity and the knockout of MPC1 promotes FASN lactylation and ultimately improves liver lipid deposition [66]. This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.